41
|
|
|
Peptidyl arginine deiminase 2 |
PAD-H19, PAD2, PDI2 |
|
42
|
|
|
Peptidyl arginine deiminase 3 |
PAD3, PDI3, UHS1 |
|
43
|
|
|
Peptidyl arginine deiminase 4 |
PAD, PAD4, PADI5, PDI4, PDI5 |
|
44
|
|
|
Peptidyl arginine deiminase 6 |
OZEMA16, PREMBL2, hPADVI |
Basal cell carcinoma, Biliary tract cancer, Breast cancer, Cancer, Cervical cancer, Colorectal cancer, Endometrial cancer, Epilepsy, Esophageal cancer, Estrogen-receptor negative breast cancer, Gastric cancer, Generalized epilepsy, Hepatocellular carcinoma, Lung cancer, Non-hodgkins lymphoma, Oocyte maturation defect, Ovarian cancer, Premature ovarian failure, Ovarian serous carcinoma, Pancreatic cancer, Prostate cancer, Squamous cell carcinomaView all (7 more) |
45
|
|
|
Progestagen associated endometrial protein |
GD, GdA, GdF, GdS, PAEG, PEP, PP14, ZIF-1 |
|
46
|
|
|
PAF1 component of Paf1/RNA polymerase II complex |
F23149_1, PD2 |
|
47
|
|
|
Platelet activating factor acetylhydrolase 1b regulatory subunit 1 |
LIS1, LIS2, MDCR, MDS, NudF, PAFAH |
17p13.3 microduplication syndrome, Carcinogenesis, Central nervous system cancer, Lissencephaly, Glioblastoma, Glioma, Hearing loss, Insomnia, Intellectual developmental disorder, Macrogyria, Major depressive disorder, Miller-dieker syndrome, Mood disorder, Myocardial infarction, Neurotic disorder, SchizophreniaView all (1 more) |
48
|
|
|
Platelet activating factor acetylhydrolase 1b catalytic subunit 2 |
HEL-S-303 |
|
49
|
|
|
Platelet activating factor acetylhydrolase 1b catalytic subunit 3 |
PAFAHG |
|
50
|
|
|
Phosphoprotein membrane anchor with glycosphingolipid microdomains 1 |
CBP, PAG |
|